Portfolio company PERKii Targeted Release Probiotics completes acquistion of ProGel Microgel Technology


Portfolio company PERKii Targeted Release Probiotics has recently acquired ProGel Microgel Technology Pty Ltd in Scrip for Scrip deal.

PERKii’s proprietary encapsulation tech reinforces their unique position in the market. By ensuring the effective targeted release and survival of active probiotics to the intestine, PERKii’s health benefits are second to none.

Congratulations to the team! To find out more details about this acquisition, read the full announcement here.